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Abstract 
 
Nutrition during pregnancy can impact on the susceptibility of the offspring to 
cardiovascular disease. Postnatal consumption of trans fatty acids (TFA), 
associated with partially hydrogenated vegetable oil (PHVO), increases the risk 
of atherosclerosis, while evidence for those trans fatty acids associated with 
ruminant-derived dairy and meat remain equivocal.  Here, we investigate the 
impact of maternal consumption of dietary PHVO (P) and ruminant milk fat (R) 
on the development of atherosclerosis in their offspring, using the transgenic 
apoE*3 Leiden mouse.  Dams were fed either chow (C) or one of three high fat 
diets: a diet reflecting the saturated fatty acid content of a ‘Western’ diet (W) or 
one enriched with either P or R.  Diets were fed during either pregnancy alone or 
pregnancy and lactation.  Weaned offspring were then transferred to an 
atherogenic diet for twelve weeks.  Atherosclerosis was assessed as lipid staining 
in cross-sections of the aorta.  There was a significant effect of maternal diet 
during pregnancy on development of atherosclerosis (p=0.013) in the offspring 
with those born of mothers fed R or P during pregnancy displaying smaller 
lesions that those fed C or W. This was not associated with changes in total or 
lipoprotein cholesterol.  Continuing to feed P during lactation increased 
atherosclerosis compared to that seen in offspring of dams fed P only during 
pregnancy (p<0.001). No such effect was seen in those from mothers fed R 
(p=0.596) or W (p=901). We conclude that dietary TFA have differing effects on 
cardiovascular risk at different stages of the lifecycle. 
 
Introduction 
 Both human epidemiological studies and animal experiments, show that 
maternal diet during pregnancy impact the susceptibility of the offspring to a 
range of chronic diseases.  Poor maternal nutrition is frequently associated with 
low birth weight and subsequently increased susceptibility to hypertension, 
obesity, type 2 diabetes, and atherosclerotic cardiovascular disease(1-4) .  Fetal 
exposure of rats to maternal low protein diets results in hypertension(5), 
impairments in renal development(6), and abnormalities in lipid(7) and glucose 
homeostasis(8). In the ApoE*3 Leiden mouse we have demonstrated that 
maternal low protein diets during pregnancy induced hypercholesterolemia and 
increased atherosclerosis in the offspring(9).    
 
More recently, it has also become apparent that maternal over-nutrition, 
particularly energy dense, high-fat diets, rich in saturated fatty acids, often 
resulting in maternal adiposity, can also programme metabolic diseases in the 
offspring.  Risk of cardiovascular disease and premature death in the offspring of 
obese women has recently been demonstrated(10).  In animal studies, maternal 
obesity is associated with increased obesity, impaired glucose homeostasis and 
hypertension in the offspring(11).  Maternal hypercholesterolemia is associated 
with increased susceptibility to atherosclerosis in both animal models(12) and 
humans(13).  In ApoE*3 Leiden mice, feeding a diet enriched in animal fat (beef 
tallow) and cholesterol raised maternal plasma cholesterol and increased the 
development atherosclerosis, independently of changes in plasma cholesterol, or 
triacylglycerol, in the offspring(14).  
Dietary TFA, particularly those in partially hydrogenated vegetable oil (PHVO) 
rich in trans 18:1 isomers, adversely affect lipoprotein concentrations(15) and 
increase the risk of developing atherosclerotic cardiovascular disease(16).    
Ruminant-derived meat and dairy products represent another source of TFA.  
However, while PHVO contains a wide range of isomers, the specific composition 
of which depends on the parent oil, ruminant-derived products contain 
predominantly vaccenic acid (VA, 18:1t11), which is produced by the bacterial 
population of the rumen.  This is particularly significant as a proportion of 
dietary VA is converted to the conjugated linoleic acid (CLA) isomer, 18:2c9,t11, 
through the action of stearoyl CoA desaturase (SCD) in the tissues of animals, 
including humans(17,18).  We have previously shown potentially beneficial effects 
of butter enriched in VA and 18:2c9,t11 CLA on lipoprotein profiles(19). 
 
In humans and animals TFA in the maternal diet can be transferred across the 
placenta into the circulation and tissues of the developing offspring with possible 
metabolic consequences(20).  A recent cohort study suggested maternal TFA 
consumption, during the second trimester of pregnancy, was positively 
associated with fetal growth rates(21), though studies in mice exposed to TFA–
enriched milk fat show retarded growth rates(22).  In the present study we 
investigated the impact of dietary these two types of TFA during pregnancy, or 
pregnancy and lactation, on the development of atherosclerosis in the offspring 
using the ApoE*3 Leiden mouse model. We hypothesized that the impact of 
maternal consumption of these TFA sources would be different as a result of the 
differing 18:1t isomer composition of the two fats and the conversion of VA (in 
ruminant -derived TFA) to 18:2c9,t11 CLA.  
Materials and methods 
 
Animal protocols 
 
All animal experiments were approved by an independent Animal Care and Use 
Committee and were performed under UK Home Office licence in accordance 
with European Union specifications.  The authors have read the ARRIVE 
guidelines(23). The animal model chosen for this study was the transgenic ApoE*3 
Leiden mouse. This was the most appropriate mouse strain for the work as an 
animal was required that would a) develop atherosclerosis (wild-type animals 
do not) and b) would do so in a manner and to an extent that is dependent upon 
dietary factors. In this strain the degree of atherosclerosis is directly 
proportional to the amount of cholesterol and amount and type of fat in the 
diet(24). Prior to the study the number of animals required was calculated using 
data from a previously reported study(9), with the aim to have 90% power to 
detect an effect of maternal diet (=0.05, =0.1). The nature of the study dictated 
that the feeding study was not performed blind, though all analysis (including 
atherosclerosis) was performed by animal number and without reference to 
treatment group.  Animals were housed and maintained as previously 
described(9).  Female C57BL/6J were obtained from Harlan UK and initially 
maintained on standard rodent chow (Rat and Mouse Diet Number 1 
Maintenance (RM1) Diet (Special Diet Services, Essex, UK)) for at least 2 weeks.  
According to the manufacturer, this diet contained 2.7% crude oil of which the 
major fatty acids were: oleic acid (0.77%), linoleic acid (0.69%), and palmitic 
acid (0.31%). At reproductive age (approximately 7 weeks), mice were 
transferred to the respective diets (see below) and mated with male, 
heterozygous, ApoE*3 Leiden transgenic mice on a C57BL/6J background.  
Transgenic mice were bred in our own facility from original founder males 
kindly provided by Dr Louis Havekes (TNO Pharma, Leiden, the Netherlands).  
Heterozygous animals were used as the ApoE*3Leiden transgene is lethal in 
homozygotes.  Pregnant females were maintained on experimental diets 
throughout pregnancy and, for the groups indicated, lactation.  Dams and 
offspring were then left undisturbed until weaning at approximately 28 days of 
age.  At weaning dams were killed, weighed, and blood and peri-renal adipose 
tissue collected.  Offspring were genotyped(9) and sexed, and female 
heterozygous ApoE*3 Leiden mice were transferred to the atherogenic diet (see 
below).  The studies were restricted to females as previous work has shown that 
the females of this transgenic strain are considerably more susceptible to 
atherosclerosis than males(9).  After 3 months of ad libitum feeding, animals were 
killed, weighed and blood and tissues (peri-renal and gonadal adipose tissue, 
liver and heart (including aortic root)) were harvested as previously 
described(9). 
 
 
Experimental diets 
 
High fat (HF) diets fed to pregnant/lactating females were prepared by blending 
powdered rodent chow (C) with 15% test fat.  TFA-enriched fats were either a 
blend of PHVOs (P) or a TFA-enriched bovine milk fat (R); the production of 
which has previously been described in detail(25).  In addition, further groups of 
females were fed on a diet containing 15% of a blend of fats (12.5% beef tallow, 
1.5% tripalmitin, and 1% corn oil) designed to reflect the most extreme intakes 
of saturated fatty acids in the Western diet (W)(26). The fatty acid composition of 
the diets is shown in Table 1 and the 18:1t isomer distribution of the two TFA-
rich fats is shown in Figure 1A (redrawn from data presented by Chardigny et 
al.(25)). While the TFA content of the W diet is comparable to that consumed in 
some human diets, the amount in the P and R diets has been deliberately 
elevated to elicit any specific effects.  In total, seven dietary regimes were used in 
pregnant/lactating females: CC, PC, PP, RC, RR, WC, WW, where the first and 
second letters represent diet in pregnancy and lactation respectively. Offspring 
were transferred onto an atherogenic diet (A) containing 15% cocoa butter and 
0.25% added cholesterol as described previously(9). Fatty acid composition of 
each diet (and mouse adipose tissue) was determined by gas-liquid 
chromatography essentially as described by Kraft et al (27). 
 
Measurement of plasma and hepatic lipids 
  
Plasma total and HDL cholesterol and total triacylglycerol were determined 
using a Randox Autoanalyser (County Antrim, UK) according to manufacturer’s 
instructions.  Non-HDL cholesterol was calculated as the difference between total 
and HDL cholesterol.  Following extraction with hexane:isopropanol (3:2) 
hepatic triacylglycerol was determined enzymatically, as previously 
described(18).  
 
Histological analyses of aortic atherosclerosis   
 The heart and aortic root were frozen, stored, and sectioned as previously 
described(9).  From the point at which all three aortic valves could be seen intact, 
every third (7μm) section (moving toward the heart) was collected and stained 
with Oil Red O.  A total of 10 sections per animal were imaged and the extent of 
atherosclerosis quantified as previously reported(9).  In most animals, there was 
clearly an increase in atherosclerosis moving towards the heart, therefore 
section number was included in statistical analysis (see below). 
 
Statistical Analysis 
 
For most variables analysis was performed using SPSS (IBM, version 20) and an 
initial comparison between a chow diet during pregnancy and lactation (CC) and 
test fats during pregnancy (PC, RC, WC) was performed by one-way analysis of 
variance (ANOVA) followed by a Dunnett post-hoc test comparing the test diets 
against CC.  All data was tested for homogeneity of variance using a Levene’s test 
and data found not to be normally distributed were log10 transformed (for which 
normal distribution was confirmed).  The effect of changing the diet during 
lactation was analysed by two-way ANOVA with pregnancy diet (P, R, W) and 
lactation diet (C, HF) as factors. Data are reported as mean ± standard deviation 
and p –values <0.05 were considered significant. Studies of developmental 
programming require special caution with regard to statistical design as 
exposure of one pregnant mouse to a particular diet will generate multiple 
offspring for subsequent analysis. Maternal diet was the fixed factor and the 
results adjusted for within litter effects(28). This adjustment removed the 
influence of having littermates within some of the groups and is an analytical 
approach we have used in our previous studies of programming(7,9). 
 
Atherosclerotic lesion area was found to be not normally distributed and still 
remain so when log10-transformed.  As a result, statistical analysis was 
performed on square-root transformed data (normal distribution confirmed) 
and data is presented as the square root of the area of staining (sqrtm2).  The 
extent of atherosclerosis clearly differed along the length of aorta observed, with 
the area affected increasing as sections were taken closer to the heart.  To 
account for this, data was analysed by repeated measures ANOVA (with section 
number as the repeated measure) using Genstat (Version 15, VSN International, 
Hemel Hemsted, UK). Data was also blocked for animal so that sections coming 
from the same animal were accounted for and for the litter from which the 
animal was derived.  An initial analysis was performed comparing each of the 
pregnancy diets (including the group fed C diet).  Further 2-way ANOVA was 
performed with pregnancy and lactation diet as the factors.   
 
Results 
 
The fatty acid composition of peri-renal adipose tissue in dams (culled after 
weaning) fed the different diets is shown in Figure 1B.  As expected, those 
mothers fed the P and R diets throughout pregnancy and lactation accumulated 
TFA in their adipose tissue and the isomer distribution mirrored that of the diet.  
As such, animals fed the P-diet accumulated predominately 18:1t9 and those fed 
the R-diet accumulated predominantly 18:1t11.  However, it was also notable 
that the R-fed animals accumulated 18:2c9,t11, in amounts that were 
disproportionate to the amount in the diet.  As would be expected, when dams 
were transferred to chow during lactation marked reductions in all TFA were 
observed in adipose tissue (data not shown). 
 
There was no difference in body weight between dams fed CC throughout 
pregnancy and lactation and those fed any of the HF diets during pregnancy 
(Table 2).  However, continuing HF in the diet of dams during lactation reduced 
maternal body weight by 11% (p<0.001), independently of the nature of the test 
fat.  Liver weights were also lower in dams fed HF diets during pregnancy and 
lactation compared to pregnancy alone (independent of type of test fat). 
Maternal plasma total, non-HDL and HDL cholesterol were all increased in 
animals fed either the P or R (but not W) diets compared to those fed C during 
pregnancy (Table 3).  Continuing HF diets during lactation further increased 
total, non-HDL and HDL cholesterol independently of the type of test fat.  Overall, 
the highest maternal cholesterol levels were seen in dams fed the R-diet 
throughout both pregnancy and lactation (RR) which was 88% higher than that 
seen in animals fed chow throughout these periods (CC).  However, as both non-
HDL and HDL cholesterol increased proportionally, there was no difference in 
the ratio between the two.  Pregnancy/lactation diet had no impact on maternal 
plasma TAG. 
 
There was no impact of maternal diet on final bodyweight of the offspring (Table 
4). Feeding the R diet during pregnancy increased both peri-renal and gonadal 
adipose tissue weights in the offspring compared to both P and W-diets.  Fatty 
acid analysis of adipose tissue from the offspring of dams fed the different diets 
showed no difference in overall composition between the groups and no 
accumulation of TFA (data not shown) by 12 weeks of age.  There was no impact 
of maternal diet on plasma total, non-HDL or HDL cholesterol or total plasma 
TAG in the offspring (Table 5). All measures of cholesterol and TAG were 
elevated in the offspring, compared to that of the mothers, as a result of presence 
of the ApoE*3 Leiden transgene and consumption of the atherogenic diet from 
weaning.  No significant effect of maternal diet was seen of hepatic TAG. 
 
The effect of different maternal diets during pregnancy on development of 
atherosclerosis in the offspring is shown in Figure 2.  It was clear that the area of 
atherosclerotic lesions increased progressively in sections closest to the heart, 
with a strong effect of section number (p<0.001).  When the impact of diet and 
section number was analysed by repeated measures ANOVA a significant effect 
of pregnancy diet was seen (p=0.013) with the two trans-fatty acid diets clearly 
resulting in lower levels of atherosclerosis than either the C or W diet.  There 
was no significant interaction between pregnancy diet and section number 
(p=0.510).  The impact of continuing feeding high fat diets during lactation was 
initially analysed by repeated measures 2-way ANOVA with pregnancy diet and 
lactation diet as factors.  This showed a specific interaction between pregnancy 
and lactation diet (p=0.039).  To clarify the impact of each of the high fat diets 
during pregnancy and lactation they are presented (figures 3A-C) and analysed 
separately.  In offspring of dams fed the P-rich diets there was a strong effect of 
lactation diet (Figure 3A, p<0.001) with offspring of those from mothers fed P 
during lactation clearly displaying more atherosclerosis than those fed C.  In 
offspring of mothers fed the R-diet (figure 3B, p=0.596) or W diet (figure 3C, 
p=0.901) there was no effect of continuing to feed the high fat diets during 
lactation.   
  
 Discussion  
The original hypothesis for this study was that fetal and neonatal exposure to the 
two sources of TFA in the maternal diet would have differing effects on the 
development of atherosclerosis due to the differing TFA isomer profiles. Few 
studies have looked at the effects of TFA in the maternal diet on disease 
susceptibility in the offspring.  As already discussed, such fatty acids cross the 
placenta and are secreted in mother’s milk proportionally to the amount in the 
diet(20).  The present study shows that TFA derived from PHVO and those from 
ruminant milk fat accumulate in the adipose tissue of dams.  Those fed R showed 
a disproportionate accumulation of 18:2c9,t11 CLA, predominantly through the 
action of stearoyl-CoA desaturase on the 18:1t11 in the dietary fat.  It therefore 
seems appropriate to assume that the developing foetuses were exposed to 
different TFA isomer concentrations depending on the diet fed to the dams.  As 
no impact of maternal diet was seen on maternal body weight, differences in 
susceptibility of the offspring to atherosclerosis could not be attributed to 
differences in maternal adiposity.   
 
We have previously shown, using the ApoE*3 Leiden mouse model, that a low-
protein maternal diet during pregnancy increased the susceptibility of the 
offspring to high dietary fat/cholesterol induced atherosclerosis(9). However, this 
was associated with increased plasma cholesterol concentrations in the 
offspring.  In contrast, we recently showed that a diet enriched in cholesterol and 
saturated fatty acids (similar to the W diet used here but including 0.25% 
cholesterol) also enhanced the development of atherosclerosis but in the 
absence of changes in plasma cholesterol in the offspring(14).  This diet resulted 
in maternal plasma cholesterol concentrations more than doubling through the 
course of pregnancy.  This supports earlier studies by Napoli et al.(12) who 
showed that the dramatic hypercholesterolemia induced by feeding cholesterol 
to pregnant ApoE knock-out mice also increased atherosclerosis in the offspring 
in the absence of changes in their plasma cholesterol. In the present study, no 
cholesterol was added to the maternal diet, maternal cholesterol was not 
increased in mothers fed the W-diet, compared to those fed chow, and the 
offspring of these animals showed no increased susceptibility to atherosclerosis.  
Both the R and P diets tended to modestly increase both non-HDL and HDL 
cholesterol with no change in the ratio of the two.   
 
It was noticeable that the high-fat diets fed during pregnancy had an effect on 
maternal body weight and liver weight. In the absence of food intake data for the 
animals (as C57 mice are prone to stress-related loss of pregnancy, this data was 
not collected), it is difficult to pinpoint the exact reason for this. However, given 
that rodents effectively defend energy intake and adjust food intake when fed 
hypercaloric diets(29), it is likely that intakes of protein and micronutrients were 
lower in these groups. This makes comparison of the current data to our 
previous study of protein restriction in the apoE*3 Leiden mouse(9) particularly 
pertinent. Demands for protein and micronutrients would be particularly high 
during lactation. 
The impact of maternal diet on the development of atherosclerosis was complex.  
The W diet showed no effect (either during pregnancy or pregnancy+ lactation) 
compared to chow diet.  However, both sources of TFA, when fed only during 
pregnancy, appeared to provide protection from atherosclerosis to 
approximately equal extents.  When maternal TFA feeding was extended through 
lactation, much of the protective effect of P was lost and clear differences were 
seen in the distribution of atherosclerosis along the length of the aorta. Unlike 
our previous work investigating the impact of maternal low-protein diets, these 
changes in susceptibility were not associated with changes in offspring plasma 
cholesterol.  It is possible that unidentified risk factors are responsible for the 
observed differences and these could include the aforementioned differences in 
protein and micronutrient intakes that may exist between chow -fed mice and 
mice fed diets of altered fatty acid composition.  However, an alternative 
explanation may be differences in the development of lesions in neonatal life.  
This has been previously advocated to explain differences in the development of 
atherosclerosis in heterozygous apoE-deficient mice born to wildtype or 
homozygous apoE knockout mothers(12). While the offspring showed no 
differences in plasma lipids, those born of apoE-deficient mothers exhibited a 
greater susceptibility to atherosclerosis.  The authors showed specific changes in 
gene expression in the aortas of affected animals and suggested that 
susceptibility to atherosclerosis may be imprinted during neonatal life.  It is 
similarly possible that in our present experiment, during fetal life alterations to 
the biology of the developing aorta, in response to the type of fat in the mother’s 
diet, have resulted in the differences in susceptibility to atherosclerosis in later 
life.  In contrast, direct exposure to P during suckling increased susceptibility to 
atherosclerosis. These results suggest that the impacts of TFA on the early 
genesis of atherosclerosis are complex and that the effects in utero are different 
to the effects during suckling. The impact of TFA on atherosclerosis in adult 
animals are well-documented. Bassett and colleagues reported that whilst PHVO 
induce atherosclerosis in LDL receptor deficient mice(30), ruminant-derived TFA 
have an anti-atherogenic effect(31), but this is the first report of their effects 
during early development. It might be speculated that the differential effects of 
TFA sources during pregnancy and lactation could be due to differences in the 
pattern of expression of pro- (and/or anti-)inflammatory factors and further 
work would be required to confirm this.  It is of note, however, that such 
programming persists even when offspring have been challenged with an 
atherogenic diet for twelve weeks. This adds weight to the hypothesis that the 
TFAs impact upon early lesion development during fetal and neonatal life.  
Further investigation will be required to examine early lesions in fetal and 
neonatal vessels in order to confirm this. Combining such an investigation with 
transcriptomic analysis of the fetal vasculature and maternal liver will contribute 
to a more detailed mechanistic understanding of the relationship between TFAs, 
maternal cholesterol metabolism and early lesion development. 
 
The only other phenotypic effect of diet was an increase in adipose tissue weight, 
both peri-renal and gonadal, in the offspring of mothers fed R.  The study 
provides no obvious explanation for the ‘programming’ of increased adiposity 
associated with maternal consumption of R.  It should be noted that the effect 
was very modest (combined increased in weight of both depots equal to about 
0.4% of total body weight) and that this needs to be confirmed in more detailed 
experiments of body composition and include measurements of food intake. 
Feeding high-fat diets during lactation had no impact upon offspring body weight 
or adiposity, which is consistent with some other but not all rodent studies of 
overfeeding in lactation(32).  However, any effect of maternal diet during suckling 
may have been masked by the feeding of the atherogenic diet post-weaning. It 
has previously been shown in rats that phenotypes programmed in lactation can 
modulated by post-weaning diet(32,33). 
 
In conclusion, consumption of TFA during pregnancy appeared to protect 
offspring from later atherosclerosis, independently of the isomeric distribution 
of the TFA.  However, if feeding is maintained during lactation, this protection 
may be partly lost, particularly when TFA derived from P are consumed.  The 
mechanisms underlying these changes remain to be established but they are not 
associated with changes in lipoprotein concentrations at the point when 
atherosclerosis was measured.   
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Figure legends 
 
Figure 1 . 18:1t isomer distribution of A) dietary test fats and B) maternal 
peri-renal adipose tissue  
 
 
Panel A: The 18:1t isomer distribution of the dietary test fats is redrawn from 
data presented by Chardigny et al.(23). Panel B: The 18:1t isomer profile of 
maternal peri-renal adipose tissue  was determined in 5 animals per group by 
gas-liquid chromatography.  For each isomer bars depicting different letters are 
significantly different (p<0.05) 
 
Figure 2. Impact of maternal pregnancy diet on development of 
atherosclerosis in the aorta of the offspring 
Atherosclerosis was determined as area of oil red-O staining of every third 
section (7m) starting from where all three valve leaflets were visible.    
Maternal diets were:  CC=Chow, PC= Partially hydrogenated vegetable oil, RC= 
trans fatty acid enriched milk fat, and WC= a blend of fats reflecting a ‘Western’ 
diet. Offspring were then fed an atherogenic diet (15% coconut oil + 0.25% 
cholesterol) for 12 weeks.  Data were analysed by repeated measures (for 
section number) ANOVA with blocking for each individual animal and litter from 
which the animals were derived. P-values for the effect of maternal diet, section 
number and the interaction between the two are presented.   
 
Figure 3.  Impact of high fat maternal diets during pregnancy or pregnancy 
and lactation on the development of atherosclerosis in the aorta of the 
offspring 
 
Atherosclerosis was determined as described in Figure 2.  Offspring were 
derived from mothers fed diet enriched in (A) partially hydrogenated vegetable 
in pregnancy (PC) or pregnancy and lactation (PP), (B) trans fatty acid-enriched 
milk fat in pregnancy (RC) or pregnancy and lactation (RR), (C) ‘Western’ fat in 
pregnancy (WC) or pregnancy and lactation (WW).  Data were analysed by 
repeated measures (for section number) ANOVA, with lactation diet and section 
number as factors, with blocking for each individual animal and litter from which 
the animals were derived.  P-values for the effect of lactation diet, section 
number and the interaction between the two are presented.   
 
Table 1. Fatty Acid Composition of Diets  
Fatty Acid  
(g/100g FA) 
Diet P Diet R Diet W Diet A 
4:0-10:0 N.D. 2.3 ND ND 
12:0 0.9 1.6 ND ND 
14:0 0.9 7.0 2.4 ND 
16:0 27.1 24.0 28.0 22.8 
17:0 ND 0.72 1.1 0.4 
18:0 12.7 5.6 14.4 29.3 
16:1 c9 ND 1.4 2.2 ND 
total 18:1 c 24.9 15.6 27.4 29.6 
total 18:1 t 15.8 15.0 2.2 N.D. 
18:2 c9,c12 10.2 11.5 11.9 10.5 
18:3 c9,c12,c15 1.0 1.3 1.2 1.0 
18:2 c9,t11 ND 2.9 0.2 ND 
ND, not detected (<0.1% total FAME).  Diet P= enriched hydrogenated vegetable 
oil, Diet R = enriched in bovine milk fat, diet W= entiched in a range of fats 
designed to approximate the fatty acid composition of a ‘Western’ diet, Diet A= 
an atherogenic diet containing 15% cocoa butter and 0.25% cholesterol.  
  
Table 2. Impact of diet on post-weaning maternal body and tissue weights 
 
 
 
 Preg 
Diet 
Lact Diet Total 2-way ANOVA (p-value) 
  C HF  preg lact preg*lact 
Body 
Weight 
(g) 
C 23.12.6   
0.0161 <0.001 0.084 
P 21.92.8 20.62.9 21.12.8 
R 22.81.6 20.41.7 21.12.0 
W 25.70.8 21 01.4 22.42.5 
Total 23.32.5 20.72.0  
Liver 
weight 
(g) 
C 1.760.36   
0.232 <0.001 0.259 
P 1.700.33 1.460.25 1.550.30 
R 1.930.26 1.500.31 1.630.35 
W 1.850.18 1.330.15 1.500.30 
Total 1.820.27 1.440.26  
Gonadal 
Fat (g) 
C 0.240.09   
0.355 0.750 0.965 
P 0.260.15 0.260.15 0.260.15 
R 0.330.16 0.350.19 0340.18 
W 0.300.13 0.330.16 0.320.15 
Total 0.290.14 0.310.17  
Peri-
renal 
fat (g) 
C 0.070.03   
0.693 0.997 0.673 
P 0.100.07 0.080.07 0.090.07 
R 0.110.07 0.100.06 0.110.06 
W 0.100.06 0.120.11 0.110.09 
Total 0.100.06 0.100.08  
1Post-hoc test not significant (P vs W, p=0.066/R vs W, p=0.061) 
Number of animals per group:  CC=13, PC=7, RC=6, WC=6, PP=11, RR=14, 
WW=12    
  
Table 3. Impact of diet on post-weaning maternal plasma lipids 
 
 Preg 
Diet 
Lact Diet Total 2-way ANOVA (p-value) 
  C HF  preg lact preg*lact 
Total Chol 
(mmol/l) 
C 3.080.57 -  
0.017 <0.001 0.089 
P 4.171.06* 4.570.81 4.420.91a 
R 4.440.93* 6.391.61 5.811.69b 
W 3.540.76 5.410.91 4.791.23a 
Total 4.060.95 5.541.40  
nonHDL Chol 
(mmol/l) 
C 1.580.27   
0.079 0.009 0.082 
P 2.240.77* 2.130.52 2.17 0.61 
R 2.360.67* 3.241.07 2.97 1.04 
W 1.890.43 2.920.76 2.580.82 
Total 2.170.64 2.810.94  
HDL chol 
(mmol/l) 
C 1.500.37   
0.013 <0.001 0.397 
P 1.930.39* 2.500.62 2.290.60a 
R 2.080.54* 3.160.67 2.840.80b 
W 1.650.44 2.490.36 2.210.55a 
Total 1.890.47 2.740.64  
nonHDL/HDL 
ratio 
C 1.080.25   
0.364 0.151 0.573 
P 1.150.31 0.930.33 1.120.33 
R 1.170.36 1.030.24 1.070.28 
W 1.190.29 1.190.30 1.190.29 
Total 1.170.30 1.050.30  
Total TAG 
(mmol/l) 
 
C 1.010.35 -  
0.220 0.392 0.572 
P 1.440.54 1.120.40 1.240.47 
R 1.440.50 1.370.65 1.390.60 
W 1.090.34 1.110.33 1.110.32 
Total 1.330.47 1.220.50  
*significantly different from dams fed Chow (C) during pregnancy 
Values within column displaying different letters are significantly different. 
Number of animals per group:  CC=13, PC=7, RC=6, WC=6, PP=11, RR=14, 
WW=12    
  
Table 4. Impact of maternal diet on body and tissue weights of offspring 
 
 Preg Diet Lact Diet Total 2-way ANOVA (p-value) 
  C HF  preg lact preg*lact 
Body 
weight 
(g) 
C 21.01.2   
0..923 0.230 0.518 
P 19.61.5 19.80.9 19.71.2 
R 20.11.6 19.21.1 19.61.4 
W 19.81.1 19.31.6 19.51.4 
Total 19.81.4 19.41.2  
Liver 
weight 
(g) 
C 1.270.18   
0.505 <0.001 0.861 
P 1.180.15 1.090.08 1.130.12 
R 1.170.11 1.090.07 1.130.10 
W 1.140.07 1.070.09 1.100.09 
Total 1.160.11 1.080.08  
Gonadal 
Fat (g)1 
C 0.200.06   
0.009 0.164 0.548 
P 0.180.03 0.140.02 0.160.04a 
R 0.230.11 0.220.11 0.220.11b 
W 0.180.07 0.160.03 0.170.05a 
Total 0.200.08 0.180.07  
Peri-
renal  
Fat (g)1 
C 0.080.03   
<0.001 0.798 0.993 
P 0.070.02 0.070.02 0.070.02a 
R 0.120.05 0.110.05 0.110.05b 
W 0.080.03 0.070.01 0.080.02a 
Total 0.090.04 0.090.04  
1Not normally distributed so statistical analysis performed on log-transformed 
data. 
Values within a column showing different letters are significantly different. 
Number of animals per group: CC=11, PC=8, RC=10, WC=10, PP=10, RR=12, 
WW=12.     
Table 5.  Impact of maternal diet on plasma lipids and liver triacylglycerol 
in offspring 
 
 Preg 
Diet 
Lact Diet Total 2-way ANOVA (p-value) 
  C HF  preg lact preg*lact 
Total Chol 
(mmol/l) 
C 9.631.21   
0.062 0.857 0.971 
P 9.051.41 8.841.02 8.931.18 
R 9.861.59 9.922.85 9.892.31 
W 10.402.21 10.281.88 10.341.98 
Total 9.821.81 9.732.13  
nonHDL 
Chol 
(mmol/l) 
C 7.991.41   
0.192 0.964 0.963 
P 7.221.29 7.021.44 7.111.34 
R 7.751.40 7.913.23 7.842.54 
W 8.342.53 8.412.36 8.382.38 
Total 7.811.85 7.822.49  
HDL chol 
(mmol/l) 
C 1.640.60   
0.816 0.733 0.560 
P 1.830.64 2.020.24 1.930.46 
R 2.100.34 2.000.71 2.050.57 
W 2.070.58 1.870.63 1.960.60 
Total 2.010.52 1.960.58  
Total TAG 
(mmol/l) 
 
C 2.250.50   
0.089 0.725 0.929 
P 2.090.38 2.120.43 2.100.40 
R 2.530.50 2.520.60 2.520.54 
W 2.400.54 2.540.76 2.470.66 
Total 2.360.50 2.410.64  
Liver TAG 
(mg/g 
liver) 
C 36.412.3   
0.346 0.118 0.305 
P 33.410.7 36.26.9   29.49.2 
R 43.314.1 30.513.0 36.314.7 
W 33.812.6 35.217.4 34.615.1 
Total 37.113.1 30.913.5  
Number of animals per group: CC=11, PC=8, RC=10, WC=10, PP=10, RR=12, 
W=12.    
  
Figure 1. Trans isomer distribution of A) dietary test fats and B) maternal 
peri-renal adipose tissue  
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Figure 3.  Impact of high fat maternal diets during pregnancy or pregnancy 
and lactation on the development of atherosclerosis in the aorta of the 
offspring 
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